Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2008-08-11 | Mr. Jorden holds a Bachelor’s degree from the University of Texas at Austin and a Master’s degree from Kellogg School of Management. |
| 2009-08-11 | Mr. Jorden has a M.M. from Northwestern University's Kellogg School and a B.B.A. from University of Texas at Austin. He holds both Certified Financial Analyst and Certified Public Accountant designations. |
| 2010-08-25 | Mr. Jorden has a M.M. from Northwestern University’s Kellogg School and a B.B.A. from University of Texas at Austin. He holds both Certified Financial Analyst and Certified Public Accountant designations. |
| 2011-08-22 | Mr. Jorden has a M.M. from Northwestern University’s Kellogg School and a B.B.A. from University of Texas at Austin. He holds both Certified Financial Analyst and Certified Public Accountant designations. |
| 2012-04-16 | David E. Jorden - Executive Chairman of the Board of the Company. Includes 458,325 shares Mr. Jorden may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan and warrants. |
| 2012-08-20 | From 2003 to 2008, he was with Morgan Stanley's Private Wealth Management group where he was responsible for equity portfolio management for high net worth individuals. Prior to Morgan Stanley, Mr. Jorden served as CFO for Genometrix, Inc., a private genomics/life sciences company. |
| 2013-04-26 | David E. Jorden - Executive Chairman of the Board of the Company. Includes 460,705 shares Mr. Jorden may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan and warrants. |
| 2013-11-12 | David E. Jorden, CPA, CFA has served as Executive Chairman since February 3, 2012... He has a MBA from Northwestern University’s Kellogg School and a B.B.A. from University of Texas at Austin. He holds both Certified Financial Analyst and Certified Public Accountant designations. |
| 2014-05-02 | David E. Jorden - Executive Chairman of the Board of the Company. Includes 601,179 shares Mr. Jorden may acquire upon the exercise of stock options approved by the Board and issued under the Companys 2002 Long-Term Incentive Plan and warrants. |
| 2014-10-01 | Mr. Jorden has a MBA from Northwestern University’s Kellogg School and a B.B.A. from University of Texas at Austin. He holds Certified Financial Analyst and Certified Public Accountant designations. |
| 2017-04-28 | David E. Jorden - Chief Executive and Chief Financial Officer of the Company. Includes shares held in an IRA and stock options. |
| 2018-08-28 | David E. Jorden - Chief Executive Officer and Chief Financial Officer of the Company. |
| 2022-10-20 | Mr. Jorden is also presently serving since June 2013 as Chief Executive Officer for Nanospectra Biosciences, Inc., a private company developing nanoparticle directed photothermal ablation technology of solid tumors. From 2003 to 2008, he was with Morgan Stanley’s Private Wealth Management group where he was responsible for equity portfolio management. Prior to Morgan Stanley, Mr. Jorden served as Chief Financial Officer for Genometrix, Inc., a private genomics/life sciences company focused on high-throughput microarray applications. Mr. Jorden was previously a principal with Fayez Sarofim & Co. Mr. Jorden has a MBA from Northwestern University’s Kellogg School and a B.B.A. from University of Texas at Austin. He is a Chartered Financial Analyst and previously held a Certified Public Accountant designation. |
Data sourced from SEC filings. Last updated: 2026-02-03